Ignite Creation Date:
2024-05-06 @ 2:54 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04460430
Status:
TERMINATED
Last Update Posted:
2022-10-25
First Post:
2020-06-29
Brief Title:
Targeting EGFRERBB2 With Neratinib in Hormone Receptor HR-PositiveHER2-negative HER2-enriched AdvancedMetastatic Breast Cancer
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-29
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-29
First Submit QC Date:
July 1 2020
Study First Post Date:
2020-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-10-25
Last Update Post Date Type:
ACTUAL